| 5.1 Nausea ‐ intraoperative |
4 |
453 |
Risk Ratio (M‐H, Random, 95% CI) |
0.67 [0.51, 0.87] |
| 5.1.1 Glycopyrrolate ‐ 0.2 mg |
2 |
89 |
Risk Ratio (M‐H, Random, 95% CI) |
0.49 [0.22, 1.09] |
| 5.1.2 Scopolamine patch |
2 |
364 |
Risk Ratio (M‐H, Random, 95% CI) |
0.71 [0.51, 0.97] |
| 5.2 Vomiting ‐ intraoperative |
4 |
453 |
Risk Ratio (M‐H, Random, 95% CI) |
0.79 [0.40, 1.54] |
| 5.2.1 Glycopyrrolate ‐ 0.2 mg |
2 |
89 |
Risk Ratio (M‐H, Random, 95% CI) |
0.45 [0.12, 1.62] |
| 5.2.2 Scopolamine patch |
2 |
364 |
Risk Ratio (M‐H, Random, 95% CI) |
0.96 [0.36, 2.59] |
| 5.3 Nausea ‐ postoperative |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
Not estimable |
| 5.4 Vomiting ‐ postoperative |
1 |
161 |
Risk Ratio (M‐H, Random, 95% CI) |
0.55 [0.41, 0.74] |
| 5.4.1 Scopolamine patch |
1 |
161 |
Risk Ratio (M‐H, Random, 95% CI) |
0.55 [0.41, 0.74] |
| 5.5 'Nausea + Vomiting' ‐ intraoperative (not pre‐specified) |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
Not estimable |
| 5.6 'Nausea + vomiting' ‐ postoperative (not pre‐specified) |
2 |
334 |
Risk Ratio (M‐H, Random, 95% CI) |
0.46 [0.25, 0.85] |
| 5.6.1 Atropine ‐ 100 mcg IT |
1 |
105 |
Risk Ratio (M‐H, Random, 95% CI) |
0.27 [0.14, 0.52] |
| 5.6.2 Atropine ‐ 100 mcg IV |
1 |
99 |
Risk Ratio (M‐H, Random, 95% CI) |
0.72 [0.45, 1.15] |
| 5.6.3 Scopolamine 0.3 mg |
1 |
130 |
Risk Ratio (M‐H, Random, 95% CI) |
0.47 [0.22, 1.01] |
| 5.7 Blurred vision |
2 |
407 |
Risk Ratio (M‐H, Random, 95% CI) |
0.84 [0.21, 3.40] |
| 5.7.1 Scopolamine patch |
1 |
203 |
Risk Ratio (M‐H, Random, 95% CI) |
1.98 [0.37, 10.57] |
| 5.7.2 Atropine ‐ 100 mcg intrathecal |
1 |
105 |
Risk Ratio (M‐H, Random, 95% CI) |
0.92 [0.18, 4.76] |
| 5.7.3 Atropine ‐ 100 mcg intravenous |
1 |
99 |
Risk Ratio (M‐H, Random, 95% CI) |
0.10 [0.00, 1.96] |
| 5.8 Anxiety/Disorientation |
2 |
407 |
Risk Ratio (M‐H, Random, 95% CI) |
0.95 [0.35, 2.58] |
| 5.8.1 Scopolamine patch |
1 |
203 |
Risk Ratio (M‐H, Random, 95% CI) |
2.97 [0.12, 72.08] |
| 5.8.2 Atropine ‐ 100 mcg intrathecal |
1 |
105 |
Risk Ratio (M‐H, Random, 95% CI) |
0.76 [0.19, 3.01] |
| 5.8.3 Atropine ‐ 100 mcg intravenous |
1 |
99 |
Risk Ratio (M‐H, Random, 95% CI) |
0.96 [0.18, 4.95] |
| 5.9 Dizziness |
2 |
333 |
Risk Ratio (M‐H, Random, 95% CI) |
0.91 [0.37, 2.24] |
| 5.9.1 Scopolamine patch |
1 |
203 |
Risk Ratio (M‐H, Random, 95% CI) |
0.99 [0.39, 2.54] |
| 5.9.2 Scopolamine 0.3 mg/5 mL IV |
1 |
130 |
Risk Ratio (M‐H, Random, 95% CI) |
0.33 [0.01, 8.03] |
| 5.10 Hypotension |
3 |
293 |
Risk Ratio (M‐H, Random, 95% CI) |
0.81 [0.58, 1.13] |
| 5.10.1 Glycopyrrolate ‐ 0.2 mg |
2 |
89 |
Risk Ratio (M‐H, Random, 95% CI) |
0.79 [0.50, 1.26] |
| 5.10.2 Atropine ‐ 100 mcg intrathecal |
1 |
105 |
Risk Ratio (M‐H, Random, 95% CI) |
0.46 [0.07, 3.11] |
| 5.10.3 Atropine ‐ 100 mcg intravenous |
1 |
99 |
Risk Ratio (M‐H, Random, 95% CI) |
0.96 [0.09, 10.15] |
| 5.11 Pruritus/itching |
2 |
407 |
Risk Ratio (M‐H, Random, 95% CI) |
0.87 [0.65, 1.18] |
| 5.11.1 Scopolamine patch |
1 |
203 |
Risk Ratio (M‐H, Random, 95% CI) |
0.92 [0.66, 1.28] |
| 5.11.2 Atropine ‐ 100 mcg intrathecal |
1 |
105 |
Risk Ratio (M‐H, Random, 95% CI) |
0.53 [0.19, 1.47] |
| 5.11.3 Atropine ‐ 100 mcg intravenous |
1 |
99 |
Risk Ratio (M‐H, Random, 95% CI) |
0.88 [0.36, 2.16] |
| 5.12 Xerostomia/dry mouth |
2 |
334 |
Risk Ratio (M‐H, Random, 95% CI) |
0.82 [0.53, 1.27] |
| 5.12.1 Atropine ‐ 100 mcg intrathecal |
1 |
105 |
Risk Ratio (M‐H, Random, 95% CI) |
0.82 [0.43, 1.59] |
| 5.12.2 Atropine ‐ 100 mcg intravenous |
1 |
99 |
Risk Ratio (M‐H, Random, 95% CI) |
0.72 [0.36, 1.41] |
| 5.12.3 Scopolamine 0.3 mg/5 mL IV |
1 |
130 |
Risk Ratio (M‐H, Random, 95% CI) |
1.25 [0.35, 4.45] |
| 5.13 Drowsiness |
1 |
130 |
Risk Ratio (M‐H, Random, 95% CI) |
3.00 [0.12, 72.31] |
| 5.13.1 Scopolamine 0.3 mg/5 mL IV |
1 |
130 |
Risk Ratio (M‐H, Random, 95% CI) |
3.00 [0.12, 72.31] |
